Overview
- Examines 5-HT2C receptor subclass as a possible therapeutic target for the development of drugs for a range of CNS disorders such as schizophrenia, depression, drug abuse, eating disorders, Parkinson’s disease and epilepsy
- Updates the functional status of the 5-HT2C receptor
- Written by an international group of accomplished leaders in this field
- Includes supplementary material: sn.pub/extras
Part of the book series: The Receptors (REC, volume 22)
Buy print copy
Tax calculation will be finalised at checkout
Table of contents (26 chapters)
-
Front Matter
About this book
Reviews
From the reviews:
“The book is well presented with good use of diagrams … . There is a good mix of international authors with acknowledged leaders in the field being responsible for some key chapters. … In summary this is a useful book describing the properties of a receptor that may well turn out to be a therapeutically important drug target with selective ligands already being evaluated in phase II trials for control of appetite.” (R. G. Hill, British Journal of Clinical Pharmacology, May, 2011)Editors and Affiliations
Bibliographic Information
Book Title: 5-HT2C Receptors in the Pathophysiology of CNS Disease
Editors: Giuseppe Di Giovanni, Ennio Esposito, Vincenzo Di Matteo
Series Title: The Receptors
DOI: https://doi.org/10.1007/978-1-60761-941-3
Publisher: Humana Totowa, NJ
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media, LLC 2011
Hardcover ISBN: 978-1-60761-940-6Published: 01 December 2010
Softcover ISBN: 978-1-61779-720-0Published: 28 January 2013
eBook ISBN: 978-1-60761-941-3Published: 30 November 2010
Series ISSN: 1048-6909
Series E-ISSN: 2524-6488
Edition Number: 1
Number of Pages: XII, 560
Topics: Neurosciences, Pharmacology/Toxicology, Human Physiology, Neurobiology, Neurology